Dipeptidyl peptidase IV(DPP IV): a novel emerging target for the treatment of type 2 diabetes-Reference-Cited by-同舟云学术

Dipeptidyl peptidase IV(DPP IV): a novel emerging target for the treatment of type 2 diabetes

Published:2009-07 Issue:4 Volume:23 Page:228-235
ISSN:1007-4376
Container-title:Journal of Nanjing Medical University
language:en
Short-container-title:Journal of Nanjing Medical University

Author:

Wu Jing,Chen Yiding,Shi Xiaoli,Gu Wei

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Computer Science

Reference50 articles.

1. Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2diabetes;Pratley;Curr Med Res Opin,2007

2. Modeling and informatics in designing anti-diabetic agents;Bharatam;Curr Pharm Des,2007

3. Incretins: a new treatment option for type 2 diabetes?;Geelhoed-Duijvestijn;Neth J Med,2007

4. DPP-4 inhibitors and their potential role in the management of type 2 diabetes;Barnett;Int J Clin Pract,2006

5. Incretin hormones in the treatment of type 2 diabetes. Part I: influence of insulinotropic gut-derived hormones(incretins) on glucose metabolism;Matuszek;Endokrynol Pol,2007

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of potential antidiabetic peptides using deep learning;Computers in Biology and Medicine;2024-09

2. Model Optimization and In Silico Analysis of Potential Dipeptidyl Peptidase IV Antagonists from GC-MS Identified Compounds in Nauclea latifolia Leaf Extracts;International Journal of Molecular Sciences;2019-11-25

3. Plant dipeptidyl peptidase-IV inhibitors as antidiabetic agents: a brief review;Future Medicinal Chemistry;2018-05-01

4. Dipeptidyl Peptidase IV Inhibitory Peptides Derived from Oat (Avena sativa L.), Buckwheat (Fagopyrum esculentum), and Highland Barley (Hordeum vulgare trifurcatum (L.) Trofim) Proteins;Journal of Agricultural and Food Chemistry;2015-10-22

5. Atom-based pharmacophore modeling, CoMFA/CoMSIA-based 3D-QSAR studies and lead optimization of DPP-4 inhibitors for the treatment of type 2 diabetes;Medicinal Chemistry Research;2014-02-02